Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Who gets radiotherapy?

E J Maher1, S Dische, E Grosch

  • 1Mount Vernon Hospital, Northwood Middlesex HA6 2RN.

Health Trends
|December 10, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selection of human embryo for IVF treatment using ensemble machine learning technique.

Morphologie : bulletin de l'Association des anatomistes·2025
Same author

Neoadjuvant Chemotherapy and Low Dose Immunotherapy in Resectable Non-small Cell Lung Cancer: A Multi-center Retrospective Cohort Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Estimating Ground Reaction Forces From Inertial Sensors.

IEEE transactions on bio-medical engineering·2024
Same author

Publisher Correction: Live-cell three-dimensional single-molecule tracking reveals modulation of enhancer dynamics by NuRD.

Nature structural & molecular biology·2023
Same author

Live-cell three-dimensional single-molecule tracking reveals modulation of enhancer dynamics by NuRD.

Nature structural & molecular biology·2023
Same author

Hepatoprotective activity of Balsamodendron mukul extract against Paracetamol-induced liver toxicity in rats: In vivo pharmacological and toxicological evaluation.

Annales pharmaceutiques francaises·2023
Same journal

On the state of the public health.

Health trends·1994
Same journal

Maternity services for drug misusers in England and Wales: a national survey.

Health trends·1994
Same journal

Dentists' responses to drug misusers.

Health trends·1994
Same journal

Leg ulcer care: an audit of cost-effectiveness.

Health trends·1994
Same journal

Deliberate self harm: the hidden population.

Health trends·1994
Same journal

Children with asthma in schools: an opportunity for "healthy alliances" between health and education authorities.

Health trends·1994
See all related articles

This study on radiotherapy for cancer patients found that palliative care was selectively used for those likely to benefit. Audits revealed consensus management and highlighted challenges in setting rigid guidelines for advanced cancer treatment.

Area of Science:

  • Oncology
  • Radiotherapy
  • Health Services Research

Background:

  • Investigated radiotherapy use in patients unsuitable for curative treatment.
  • Examined palliative radiotherapy practices and challenges in guideline development.
  • Assessed current practices for potential improvements and prospective audit.

Purpose of the Study:

  • Clarify current palliative radiotherapy practices.
  • Examine difficulties in establishing treatment guidelines.
  • Provide a basis for prospective audit and cost-benefit analysis.

Main Methods:

  • Grouped patients by curability (curable/incurable) and treatment intent (radical/palliative).
  • Conducted initial audit of radiotherapy schedules and national practice alignment.

Related Experiment Videos

  • Performed a second audit in 1989 with a costing exercise.

    • Main Results:

    • Radiotherapy guidelines aligned with national practice.
    • Reduced median fractions per course observed post-audit in both patient groups.
    • Palliative radiotherapy was selectively administered to patients with high benefit potential.

    Conclusions:

    • Consensus management in radiotherapy was influenced by informal internal audits.
    • Highlighted decision-making complexities in advanced non-metastasized cancer.
    • Confirmed challenges in establishing rigid palliative therapy guidelines and conducting cost-benefit analyses.